Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Tomball › NPI 1972134062
Physician

North Houston Internal Medicine and Pediatric Clinic PLLC

North Houston Internal Medicine and Pediatric Clinic PLLC was paid $1.88M by Medicaid between Aug 2020 and Dec 2024, across 93 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.

33Billing provider infoNORTH HOUSTON INTERNAL MEDICINE AND PEDIATRIC CLINIC PLLC
TOMBALL, TX 77375
33aNPI1972134062assigned 01/28/2020
33bProvider typePediatrics Physician
28Total paid$1.88M
24GClaims82,312
24DCodes billed93
24AFirst – last monthAug 2020 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in Texas

Rank by total paid#257 of 1,136
Median peer was paid$329K
This provider vs. median5.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20201,579$30K
202112,018$252K
202223,503$510K
202326,914$622K
2024incomplete18,298$464K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 29% 14,972 12,168 $540K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 15% 5,467 4,688 $275K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 11% 2,700 2,480 $204K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 10% 2,380 2,324 $194K
90460 Immunization administration through 18 years of age via any route, first or only component 7.1% 10,724 5,238 $133K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 7.0% 3,622 3,370 $132K
99000 4.7% 8,537 7,685 $89K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 4.4% 946 925 $83K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 3.0% 2,593 2,289 $56K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2.4% 3,760 3,479 $45K
96110 Developmental screening, with scoring and documentation, per standardized instrument 1.1% 2,570 1,856 $20K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 152 148 $14K
81 more codes
90461 <1% 2,892 $11K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 78 $10K
99381 <1% 139 $10K
87807 <1% 1,020 $9K
99050 <1% 515 $8K
90474 <1% 783 $7K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 265 $6K
90670 <1% 1,433 $5K
92551 <1% 1,025 $4K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 296 $4K
S8301 Infection control supplies, not otherwise specified <1% 363 $3K
86328 <1% 61 $3K
99203 Doctor's office visit, new patient (routine) <1% 42 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 30 $1K
99383 <1% 13 $1K
90680 <1% 1,268 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 27 $1K
90686 <1% 1,577 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 111 $942.49
90677 <1% 423 $761.79
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 53 $730.19
96160 <1% 2,338 $545.09
0071A <1% 13 $480.00
81002 <1% 166 $418.33
98960 <1% 145 $253.81
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 14 $196.76
99051 <1% 27 $161.70
90633 <1% 743 $130.00
90648 <1% 1,299 $70.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 290 $68.59
84030 <1% 43 $50.82
S8101 Holding chamber or spacer for use with an inhaler or nebulizer; with mask <1% 13 $27.00
90723 <1% 870 $20.00
92587 <1% 12 $18.24
90473 <1% 13 $15.68
G0447 Face-to-face behavioral counseling for obesity, 15 minutes <1% 628 $15.00
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable <1% 14 $8.75
99172 <1% 178 $8.75
94760 <1% 18 $4.31
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 12 $2.04
G9903 Patient screened for tobacco use and identified as a tobacco non-user <1% 21 $0.35
G8482 Influenza immunization administered or previously received 0% 95 $0.00
J8499 Prescription drug, oral, non chemotherapeutic, nos 0% 73 $0.00
99173 0% 472 $0.00
1160F 0% 180 $0.00
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 0% 92 $0.00
3078F 0% 44 $0.00
1033F 0% 195 $0.00
1159F 0% 218 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 0% 59 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 0% 17 $0.00
90707 0% 83 $0.00
90734 0% 24 $0.00
3725F 0% 30 $0.00
90715 0% 12 $0.00
G8483 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) 0% 76 $0.00
94664 0% 13 $0.00
90700 0% 73 $0.00
90710 0% 14 $0.00
G8783 Normal blood pressure reading documented, follow-up not required 0% 15 $0.00
1126F 0% 339 $0.00
36416 0% 715 $0.00
90656 0% 339 $0.00
H0033 Oral medication administration, direct observation 0% 233 $0.00
3008F 0% 375 $0.00
91307 0% 19 $0.00
3074F 0% 97 $0.00
97802 0% 90 $0.00
90744 0% 41 $0.00
1036F 0% 14 $0.00
S9451 Exercise classes, non-physician provider, per session 0% 58 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 14 $0.00
96127 0% 135 $0.00
90698 0% 136 $0.00
90716 0% 97 $0.00
S3620 Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) 0% 13 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 32 $0.00
36415 Collection of venous blood by venipuncture 0% 15 $0.00
90651 0% 26 $0.00
4000F 0% 31 $0.00
90696 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANNAMALAI, RAJASEKARAN (OWNER/PROVIDER)